UnknownPhase 1NCT02790762
Human Umbilical Cord-Mesenchymal Stem Cells for Pneumoconiosis
Studying Pneumoconiosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Shenzhen Hornetcorn Bio-technology Company, LTD
- Principal Investigator
- Guo Q Li, ProfessorThe second Affiliated Hospital of University of Soth China
- Intervention
- Human umbilical cord mesenchymal stem cells(biological)
- Enrollment
- 10 target
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2016 – 2017
Study locations (1)
- The second Affiliated Hospital of University of Soth China, Hengyang, Hunan, China
Collaborators
The Second Hospital University of South China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02790762 on ClinicalTrials.govOther trials for Pneumoconiosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06563674Acceptance-based Healthy Lifestyles Program for Patients With PneumoconiosisChinese University of Hong Kong
- RECRUITINGPHASE3NCT05288179Efficacy and Safety of Pirfenidone Capsules in the Treatment of PneumoconiosisBeijing Continent Pharmaceutical Co, Ltd.
- RECRUITINGNCT07077382Pneumoconiosis and Dust Exposure China CohortChina-Japan Friendship Hospital